EGFR and glioblastoma: In fact, a large-scale sequencing study indicated that 57% of GBM patient samples contain mutation, rearrangement, altered splicing, and/or focal amplification of EGFR and that various mutations often co-occur with EGFR rearrangement and/or amplification [42].